Targeting CDCA3 Enhances Sensitivity to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer

被引：0
|
作者：
Adams, M. [1 ]
Burgess, J. [1 ]
Richard, D. [1 ]
O'Byrne, K. [2 ]
机构：
[1] Inst Hlth & Biomed Innovat, Translat Res Inst, Woolloongabba, Qld, Australia
[2] Inst Hlth & Biomed Innovat, Translat Res Inst, Brisbane, Qld, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
non-small cell lung cancer; prognostic factor; cisplatin chemotherapy;
D O I：
10.1016/j.jtho.2017.09.468
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA 03.11
引用
收藏
页码：S1810 / S1811
页数：2
相关论文
共 50 条
  • [21] Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy
    Omersa, Daniel
    Cufer, Tanja
    Marcun, Robert
    Lainscak, Mitja
    RADIOLOGY AND ONCOLOGY, 2017, 51 (01) : 15 - 22
  • [22] Evaluation of Platinum-based Therapy Response in Non-Small Cell Lung Cancer
    Ippolito, M.
    Stefano, A.
    Russo, G.
    Gieri, S.
    Cosentino, S.
    Mure, G.
    Baldari, S.
    Sabini, M. G.
    Fraggetta, F.
    Vitabile, S.
    Gilardi, M. C.
    Banna, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S714 - S715
  • [23] Meta-analysis of P53 expression and sensitivity to platinum-based chemotherapy in patients with non-small cell lung cancer
    Lin, Sheng
    Li, Xiaoqin
    Lin, Ming
    Yue, WenXiang
    MEDICINE, 2021, 100 (05) : E24194
  • [24] DECREASE OF CIRCULATING TUMOR CELLS ASSOCIATES WITH RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER, BUT NOT WITH SMALL CELL LUNG CANCER
    Gauler, Thomas C.
    Theegarten, Dirk
    Parr, Annette
    Schuhr, Ivonne
    Schmid, Kurt W.
    Eberhardt, Wilfried
    Schuler, Martin
    Hoffmann, Andreas-Claudius
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1114 - S1114
  • [25] Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World
    Giacomo Pelizzari
    Francesco Cortiula
    Marco Giavarra
    Michele Bartoletti
    Camilla Lisanti
    Vanessa Buoro
    Monica Cattaneo
    Ciro Rossetto
    Simona Rizzato
    Fabio Puglisi
    Marianna Macerelli
    Gianpiero Fasola
    Alessandro Follador
    Drugs & Aging, 2020, 37 : 677 - 689
  • [26] Comorbidity as a Prognostic Factor in Elderly Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Sazdanic-Velikic, Danica
    Tepavac, Aleksandar
    Lalic, Nensi
    Stojkovic, Ivana
    Secen, Nevena
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S914 - S914
  • [27] Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy
    Mellema, Wouter W.
    van der Hoek, Dorien
    Postmus, Pieter E.
    Smit, Egbert F.
    LUNG CANCER, 2014, 86 (01) : 73 - 77
  • [28] TOLERABILITY OF STANDARD DOSE OF PLATINUM-BASED CHEMOTHERAPY IN FIT ELDERLY PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Zenke, Y.
    Umemura, S.
    Yoh, K.
    Matsumoto, S.
    Niho, S.
    Goto, K.
    Ohmatsu, H.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2013, 24
  • [29] Analysis of prognosis in non-small cell lung cancer patients with platinum-based chemotherapy and bone marrow suppression
    Han, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer
    Thatcher, N
    Faivre-Finn, C
    Blackhall, F
    Anderson, H
    Lorigan, P
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5051S - 5056S
12345